Nicholas P. Restifo

Executive Officer at Medici Therapeutics.

Raised on Medici Therapeutics filings

$14.8M

of $14.8M offered across 1 Form D filing

Form D filings: 1
Teammates: 3
Last filing: Dec 4, 2025

Company

Medici Therapeutics

Biotech · Boston, MA

Tumor-infiltrating lymphocyte cell therapy for cancer

Tumor-infiltrating lymphocyte cell therapy for cancer

Investors: 11
Founded: 2021

Investors: 11
Sector: Biotech
Founded: 2021
HQ: Boston, MA

Medici Therapeutics filings

Medici Therapeutics Form D filings
Filed	Security	Sold of offered	Filing
Dec 4, 2025	Equity	$14.8M/ $14.8M	Form D

EquityFiled Dec 4, 2025Form D
$14.8M/ $14.8M

Works with

Also named on Medici Therapeutics filings

Denitsa MilanovaChief Executive Officer, Form D signerForm D signer Matthew RabinowitzDirector David ThompsonExecutive Officer